Mary Kay Inc. recently sponsored and funded in part the 2021 Society for Investigative Dermatology (SID) Annual Meeting. In this virtual meeting, the company unveiled new skin health research on a botanical extract that reduces inflammation from retinol through the TRPV-1 receptor, and announced four $25,000 grants that will be awarded to researchers in the skin health and skin disease categories. Winners will be announced in 2022.
“Mary Kay is a firm believer that a collaborative effort is crucial in identifying new discoveries and innovation,” said Dr. Lucy Gildea, Mary Kay’s Chief Scientific Officer. “Events like the annual Society for Investigative Dermatology conference bring together the brightest minds working to advance the future of the field. May Kay is excited to be part of this scientific community, and we know these research grants will further help ongoing efforts in skin research. We are thrilled to see what scientists uncover next.”
Mary Kay’s research in retinol-induced inflammation reduction explores the combination of retinol and plant-derived TRPV-1 antagonist and anti-inflammatory botanical extract. Preliminary results show a reduction in erythema, edema and dryness.
“Our Research & Development team is consistently developing new skin care solutions for women around the world,” said Dr. Gildea. “Participating in events such as the SID annual meeting allows us to learn and share relevant research so we can continue to deliver meaningful benefits and amazing products to consumers.”
